Antibiotic Treatment of Severe Exacerbations of Chronic Obstructive Pulmonary Disease with Procalcitonin: A Randomized Noninferiority Trial
暂无分享,去创建一个
Mario Plebani | Giorgio Walter Canonica | Fabrizio Luppi | Antonio Spanevello | G. Canonica | B. Beghé | L. Fabbri | A. Spanevello | A. Verduri | M. Barbaro | F. Luppi | M. Plebani | R. D'amico | A. Papi | S. Balduzzi | Alessia Verduri | Roberto D’Amico | Sara Balduzzi | Roberto Vicini | Anna Liverani | Valentina Ruggieri | Maria Pia Foschino Barbaro | Alberto Papi | Leonardo Michele Fabbri | Bianca Beghè | R. Vicini | A. Liverani | Valentina Ruggieri | V. Ruggieri
[1] M. R. Siddiqui,et al. Global Initiative for Chronic Obstructive Lung Disease (GOLD) , 2017 .
[2] Meilan K. Han,et al. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. , 2014, American journal of respiratory and critical care medicine.
[3] X. Ou,et al. [Exacerbation phenotyping in chronic obstructive pulmonary disease]. , 2014, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[4] Antonio Anzueto,et al. Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[5] M. Briel,et al. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. , 2013, JAMA.
[6] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[7] F. Tubach,et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2013, Evidence-based child health : a Cochrane review journal.
[8] L. Richeldi,et al. The role of biomarkers in low respiratory tract infections. , 2012, European journal of internal medicine.
[9] C Michael Stein,et al. Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.
[10] C. Agustí,et al. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD , 2012, European Respiratory Journal.
[11] K. Kostikas,et al. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. , 2012, Chest.
[12] M. Puhan,et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.
[13] M. Woodhead. New guidelines for the management of adult lower respiratory tract infections , 2011, European Respiratory Journal.
[14] C. Nolan,et al. The “susceptibility to exacerbation” phenotype in COPD and response to pulmonary rehabilitation , 2011 .
[15] C. Brightling,et al. Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD , 2010, Chest.
[16] J. Maurer. Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2011 .
[17] J. DiNicolantonio,et al. Azithromycin for prevention of exacerbations of COPD. , 2011, The New England journal of medicine.
[18] T. Bregenzer,et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. , 2009, JAMA.
[19] L. Masserini. L'uso dei farmaci in Italia , 2008 .
[20] M. Briel,et al. Procalcitonin to initiate or withhold antibiotics in acute respiratory tract infections , 2008 .
[21] M. Christ-Crain,et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. , 2007, Chest.
[22] M. Christ-Crain,et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.
[23] G. Donaldson,et al. COPD exacerbations · 1: Epidemiology , 2006, Thorax.
[24] A. Torres,et al. Guidelines for the management of adult lower respiratory tract infections , 2005, European Respiratory Journal.
[25] M. Christ-Crain,et al. Procalcitonin in bacterial infections--hype, hope, more or less? , 2005, Swiss medical weekly.
[26] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[27] G. Canonica,et al. A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire , 2005, Allergy.
[28] M. Christ-Crain,et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.
[29] Henry D. Isenberg,et al. Clinical Microbiology Procedures Handbook , 2004 .
[30] Andrew J. White,et al. Chronic obstructive pulmonary disease • 6: The aetiology of exacerbations of chronic obstructive pulmonary disease , 2003, Thorax.
[31] D. Postma,et al. Chronic obstructive pulmonary disease. , 2002, Clinical evidence.
[32] B. Grant,et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.
[33] R. Rodríguez-Roisín,et al. Toward a consensus definition for COPD exacerbations. , 2000, Chest.
[34] A. Tosteson,et al. Changes in dyspnea, health status, and lung function in chronic airway disease. , 1995, American journal of respiratory and critical care medicine.
[35] G. Mathis,et al. Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. , 1993, Clinical chemistry.
[36] J. E. Brazier,et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.
[37] J. Hankinson,et al. Standardization of spirometry. , 1988, The American review of respiratory disease.
[38] Buist As. Standardization of spirometry. , 1987 .
[39] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[40] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[41] C. Wells,et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.